Timing Important for COVID Vax in Patients With Blood Cancers Timing Important for COVID Vax in Patients With Blood Cancers
Two further studies show that response to COVID-19 vaccination is impaired in patients with blood cancers, but experts still recommended vaccination, because COVID-19 can be deadly in this population.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 22, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Johnson & Johnson Reports 2021 First-Quarter Results
New Brunswick, N.J. (April 20, 2021) – Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2021. “Johnson & Johnson delivered a strong first quarter performance led by the above market growth of our Pharmaceutical business and continued recovery in Medical Devices,” said Alex Gorsky, Chairman and Chief Executive Officer. “The ability to deliver these results while simultaneously advancing our robust pipeline of life-enhancing medicines, products and solutions during these times is a testament to the strength and resilience of our business and the dedication of the 135,000...
Source: Johnson and Johnson - April 20, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Janssen Provides Update on Phase 3 ACIS Study in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with ERLEADA ® (apalutamide) and ZYTIGA® (abiraterone acetate) Plus Prednisone Combination
RARITAN, N.J., April 19, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that regulatory submissions based on the Phase 3 ACIS study, which evaluated the combination of ERLEADA® (apalutamide) and ZYTIGA® (abiraterone acetate) plus prednisone in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC), will not be pursued. As presented at the American Society of Clinical Oncology’s Genitourinary (ASCO GU) Cancers Symposium in February 2021, the ACIS study met its primary endpoint of radiographic progression-free survival (rPFS); ho...
Source: Johnson and Johnson - April 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Exclusive: Inside the Facilities Making the World ’s Most Prevalent COVID-19 Vaccine
If you’ve been vaccinated for COVID-19, chances are pretty high that you’re benefiting from a product made by BioNTech. The German biotech company, co-founded by a husband-and-wife team of scientists, developed the vaccine that became not only the first to earn authorization in the U.S. for COVID-19 in December but also the first ever based on a new technology involving the genetic material mRNA. In interviews in December and March, co-founders Ugur Sahin and Ozlem Tureci spoke about their whirlwind year and their partnership with U.S. pharmaceutical company Pfizer to test and manufacture the vaccine. Over thre...
Source: TIME: Health - April 19, 2021 Category: Consumer Health News Authors: Alice Park and Aryn Baker/Marburg, Germany Tags: Uncategorized COVID-19 Exclusive feature longform Magazine photography Source Type: news

Biden Administration Ends Limit on Fetal Tissue Research
The decision reverses Trump administration rules and allows scientists to use tissue derived from elective abortions to develop treatments for diseases including cancer and AIDS. (Source: NYT Health)
Source: NYT Health - April 17, 2021 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Fetal Tissue Research Tissue (Human) Science and Technology Abortion Vaccination and Immunization Coronavirus (2019-nCoV) Health and Human Services Department National Institutes of Health International Society for St Source Type: news

A Cancer Vaccine Is In Development By COVID-19 Vaccine Maker, Using The Same Tech
In principle, mRNA can be applied for many immune system-related illnesses. (Source: Reuters: Health)
Source: Reuters: Health - April 17, 2021 Category: Consumer Health News Source Type: news

Studies suggest people with blood cancers may not be optimally protected after COVID-19 vaccination
(American Society of Hematology) Two new studies published in Blood suggest that the mRNA COVID-19 vaccine may have reduced efficacy in individuals with chronic lymphocytic leukemia (CLL) and multiple myeloma, two types of blood cancer. According to researchers, these studies could help inform the ideal time for vaccination of these populations. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 16, 2021 Category: Infectious Diseases Source Type: news

Scientists Report Creating the First Embryo With Human and Non-Human Primate Cells
In a ground-breaking experiment, researchers have successfully created the first human-monkey chimera. The work, published in the journal Cell, describes the the first embryo containing both human and monkey cells that was cultured for 20 days. Led by Juan Carlos Izpisua Belmonte, the study represents the culmination of decades of work in understanding early embryo development in non-human species, which Belmonte hopes will now apply to humans. But it is bound to raise serious ethical questions about the implications of combining human cells with those from a different species (even if it is a closely related one), and the...
Source: TIME: Health - April 15, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Source Type: news

Personalized Cancer Vaccine Shows Early Promise Across Tumor Types Personalized Cancer Vaccine Shows Early Promise Across Tumor Types
In a phase 1 trial, the vaccine, called PGV-001, was well tolerated. It was given to 13 patients with multiple myeloma who had a high risk of recurrence after surgery or autologous stem cell transplant.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 15, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Therapeutic Cancer Vaccine Shows Promise Against Multiple Tumor Types
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 13, 2021 Category: Cancer & Oncology Tags: Oncology, Pharmacy, Research, News, Source Type: news

COVID-19 Vaccine Failure in Patients With Blood Cancers COVID-19 Vaccine Failure in Patients With Blood Cancers
Almost half of patients with hematologic malignancies failed to produce antibodies against SARS-CoV-2 after full vaccination and thus remained at risk for COVID-19 infection.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 13, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Therapeutic Cancer Vaccine Shows Promise Against Multiple Tumor Types
TUESDAY, April 13, 2021 -- Marc Baum went through all the usual steps to treat his bladder cancer -- a couple of surgeries, radiation therapy and chemotherapy, all in a three-month period. But doctors hope that an extra step -- an experimental... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 13, 2021 Category: General Medicine Source Type: news

Therapeutic Cancer Vaccine Shows Promise Against Multiple Tumor Types
Title: Therapeutic Cancer Vaccine Shows Promise Against Multiple Tumor TypesCategory: Health NewsCreated: 4/13/2021 12:00:00 AMLast Editorial Review: 4/13/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 13, 2021 Category: Cancer & Oncology Source Type: news

AACR: Personalized Vaccine for Cancer Tolerated, Feasible
Vaccine well tolerated in 13 patients; vaccine showed potential benefit in patients with solid tumors, multiple myeloma in phase 1 trial (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 12, 2021 Category: Cancer & Oncology Tags: Oncology, Pathology, Conference News, Source Type: news

COVID Vaccines Might Not Protect Certain Cancer Patients
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 12, 2021 Category: Cancer & Oncology Tags: Infections, Oncology, News, Source Type: news

AACR: Personalized Vaccine for Cancer Tolerated, Feasible
MONDAY, April 12, 2021 -- A personalized vaccine can be synthesized and is feasible for administration to patients with cancer, according to a study presented during Week 1 of the annual meeting of the American Association for Cancer Research, held... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 12, 2021 Category: Pharmaceuticals Source Type: news

COVID Vaccines Might Not Protect Certain Cancer Patients
MONDAY, April 12, 2021 -- People with cancers of the blood, bone marrow or lymph nodes are at an increased risk of not making protective coronavirus antibodies after COVID-19 vaccination, a new study warns. The risk is particularly high for those... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 12, 2021 Category: General Medicine Source Type: news

COVID Vaccines Might Not Protect Certain Cancer Patients
Title: COVID Vaccines Might Not Protect Certain Cancer PatientsCategory: Health NewsCreated: 4/12/2021 12:00:00 AMLast Editorial Review: 4/12/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 12, 2021 Category: Cancer & Oncology Source Type: news

What Are Toxin-Mediated Diseases?
Discussion A poison is a generic term for “a substance with an inherent property that tends to destroy life or impair health.” A toxin is more specific and is “any poison produced by an organism, characterized by antigenicity in certain animals and high molecular weight, and including the bacterial toxins that are the causative agents of tetanus, diphtheria, etc., and such plant and animal toxins as ricin and snake venom.” A toxin does not include those substances that are made synthetically produced. Venom is also a toxin that is used by animals and insects for predation or defense which can cause ...
Source: PediatricEducation.org - April 12, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Personalized cancer vaccine is safe, shows potential benefit against cancer
(The Mount Sinai Hospital / Mount Sinai School of Medicine) A personalized cancer vaccine developed with the help of a Mount Sinai computational platform raised no safety concerns and showed potential benefit in patients with different cancers, including lung and bladder, that have a high risk of recurrence, according to results from an investigator-initiated phase I clinical trial presented during the virtual American Association for Cancer Research (AACR) Annual Meeting 2021, held April 10-15. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 10, 2021 Category: Cancer & Oncology Source Type: news

UPMC studies Covid-19 vaccine effectiveness in immunocompromised, seniors
Two new studies from the University of Pittsburgh School of Medicine and UPMC are getting at the effectiveness of Covid-19 vaccines in immunocompromised and vulnerable populations, with good news about how well the vaccine does in seniors who live in long-term care facilities but warnings about the effectiveness in people with some types of cancer. Researchers said Friday that there's increasing signs that efficacy of Covid-19 vaccines in people with blood, bone marrow or lymph node cancer don't… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 9, 2021 Category: Pharmaceuticals Authors: Paul J. Gough Source Type: news

Exclusive: CDC Director Dr. Rochelle Walensky Unveils Agency Initiative to Address Racism in Health
If the COVID-19 pandemic has taught us anything, it is that health is a commodity bestowed readily on some and denied to so many others. Within months of the COVID-19 virus reaching U.S. shores, it became clear that the disease hit certain groups harder, contributing to more severe illness and higher hospitalization and death rates among Black, Latinx and American Indian/Alaska Native communities, and those of lower socioeconomic status. The reason for that skewed impact doesn’t have so much to do with biology or genetics as it does a myriad of other factors, such as where people live, how clean the air they breathe ...
Source: TIME: Health - April 8, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

NIDCR's Spring 2021 E-Newsletter
Having trouble viewing this email? View it as a Web page. NIDCR's Spring 2021 E-Newsletter In this issue: NIDCR News Funding Opportunities & Related Notices NIH/HHS News Subscribe to NICDR News Science Advances   Grantee News   NIDCR News NIDCR & NIH Stand Against Structural Racism NIDCR Director Rena D’Souza, DDS, MS, PhD, said in a statement that there is no place for structural racism in biomedical research, echoing remarks from NIH Director Francis Collins, MD, PhD, in his announcement of a new NIH ...
Source: NIDCR Science News - April 7, 2021 Category: Dentistry Source Type: news

FDG-PET/CT effective for staging in new breast cancer
FDG-PET/CT scans are a valuable tool for staging women newly diagnosed wit...Read more on AuntMinnie.comRelated Reading: Keto diet improves PET/CT of cardiac sarcoidosis SNMMI provides update on COVID-19 vaccine and PET/CT FDG-PET/MRI offers option for pediatric Hodgkin lymphoma FDG-PET/CT shows COVID-19 vaccine uptake Is there a place for whole-body cancer screening? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 7, 2021 Category: Radiology Source Type: news

World Health Day 2021: Building a fairer, healthier world
Wednesday 7 April marksWorld Health Day, a day organised by the World Health Organization (WHO) to highlight a particular global health issue. This year, it aims to spotlight health equity.Health equity is the absence of avoidable and unfair differences in health. The COVID-19 pandemic and its uneven impacts worldwide has brought attention to long-standing inequities in living and working conditions which affect people ’s health outcomes.This World Health Day, WHO is calling on leaders to address these inequities, to monitor them, and to ensure people have access to quality health care.Cochrane is committed to promot...
Source: Cochrane News and Events - April 6, 2021 Category: Information Technology Authors: Rachel Klabunde Source Type: news

Breast screening rates rebound after COVID, but deficit remains
U.S. mammography screening rates have rebounded since plunging in the firs...Read more on AuntMinnie.comRelated Reading: Adenopathy may occur after COVID-19 vaccination Skipping mammograms boosts risk of breast cancer death COVID-19 vaccine affects imaging results, researchers warn How many cancers were missed during the COVID-19 pandemic? Patients in Canada missing recommended cancer screenings (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 2, 2021 Category: Radiology Source Type: news

Novel cancer vaccine targets oncogenes known to evade immunity in melanoma and neuroblastoma models
(Children's National Hospital) A personalized tumor cell vaccine strategy targeting Myc oncogenes combined with checkpoint therapy creates an effective immune response that bypasses antigen selection and immune privilege, according to a pre-clinical study for neuroblastoma and melanoma. The neuroblastoma model showed a 75% cure with long-term survival, researchers at Children's National Hospital found. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 2, 2021 Category: International Medicine & Public Health Source Type: news

Researchers devise more efficient, enduring CAR gene therapy to combat HIV
FINDINGSA UCLA research team has shown that using a truncated form of the CD4 molecule as part of a gene therapy to combat HIV yielded superiorand longer-lastingresults in mouse models than previous similar therapies using the CD4 molecule.This new approach to CAR T gene therapy — a type of immunotherapy that involves genetically engineering the body ’s own blood-forming stem cells to create HIV-fighting T cells— has the potential to not only destroy HIV-infected cells but to create “memory cells” that could provide lifelong protection from infection with the virus that causes AIDS.BACKGROUNDC...
Source: UCLA Newsroom: Health Sciences - April 1, 2021 Category: Universities & Medical Training Source Type: news

Cancer Vaccines: Raising a T Cell Army
Vaccines against various forms of cancer prime the immune system to attack. (Source: The Scientist)
Source: The Scientist - April 1, 2021 Category: Science Tags: Sponsored Infographics Source Type: news

SNMMI provides update on COVID-19 vaccine and PET/CT
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has updated it...Read more on AuntMinnie.comRelated Reading: SNMMI issues new guidelines on V/Q scans FDG-PET/CT shows COVID-19 vaccine uptake PET/CT guidance offers valuable approach to lung biopsies SNMMI 2020: PSMA-PET/CT changes prostate cancer management SNMMI 2020: How nuclear medicine handled COVID-19 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 31, 2021 Category: Radiology Source Type: news

ASTRO survey finds rise in advanced-stage cancer
The disruption of cancer screening programs during the COVID-19 pandemic ha...Read more on AuntMinnie.comRelated Reading: ASTRO lauds Biden's CMS administrator nomination ASTRO endorses COVID-19 vaccine for cancer patients ASTRO lauds delay of radiation therapy payment reform Race, ethnicity vary in radiation therapy trials Radiation therapy access grows, but not in rural areas (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 31, 2021 Category: Radiology Source Type: news

Fitness, Fundraising and Friendship for Prostate Cancer
By Syed Neaz Ahmad FRSALONDON, Mar 30 2021 (IPS-Partners) Over the Pandemic months, most activities – social, cultural, economic & philanthropic have been hit hard. The worst-hit has been patients suffering from serious diseases. Most have shied away from visiting their doctors and referral fell by 52,000 due to Covid-19. However, as they say, life goes on, and in this case, death goes on too. Prostate Cancer UK – a charity exclusive to the disease – report that despite awareness and development in technology – every 45 minutes a man dies of this dreaded disease. It is the ‘most commonly ...
Source: IPS Inter Press Service - Health - March 30, 2021 Category: International Medicine & Public Health Authors: Syed Neaz Ahmad FRSA Tags: Health Source Type: news

COVID Vaccine Gives Less Protection for Some Cancer Patients
Millions of people across the United States have begun receiving their COVID-19 vaccines, and restrictions are lifting in many public spaces such as restaurants and bars. Mesothelioma patients may be looking forward to returning to life as it was before the pandemic. However, a new study reports that the COVID-19 vaccine may not sufficiently protect patients with compromised or weakened immune systems. The study results suggest that people with cancer or who are undergoing cancer treatment may still be highly vulnerable to COVID-19 even after their vaccination. Researchers published their findings earlier this m...
Source: Asbestos and Mesothelioma News - March 30, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Vaccine advice for adults living with adults who are immunosuppressed
The Joint Committee on Vaccination and Immunisation (JCVI) has advised the government to prioritise people for the coronavirus (COVID-19) vaccine who are over 16 and living with adults who have weakened immune systems, such as those with blood cancer, HIV or those on immunosuppressive treatment including chemotherapy. (Source: NHS Networks)
Source: NHS Networks - March 30, 2021 Category: UK Health Source Type: news

Call to Eradicate All Types of HPV Cancers, not Just Cervical Call to Eradicate All Types of HPV Cancers, not Just Cervical
Widespread gender-neutral vaccination against human papilloma virus (HPV) would eliminate HPV infections that cause many different cancer types, not just cervical cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 25, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

What ’s Next For Moderna Post-Covid-19: CEO Stéphane Bancel Details mRNA Pipeline
One of the world ’s first mRNA vaccines made Bancel a billionaire—and now the biotech CEO discusses his plans to use the mRNA breakthrough for cancer, genetic disorders, and even a better flu vaccine. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 24, 2021 Category: Pharmaceuticals Authors: Leah Rosenbaum, Forbes Staff Tags: Innovation /innovation Healthcare /healthcare Science /science Business /business Editors' Pick editors-pick Coronavirus Daily Cover daily-cover Source Type: news

Exploiting cancer cells to aid in their own destruction
(University of Chicago) Researchers   have developed a new therapeutic vaccine that uses a patient's own tumor cells to train their immune system to find and kill cancer. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 24, 2021 Category: Biology Source Type: news

Vaccination against mutated protein tested in brain tumor patients for the first time
(German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)) Tumor vaccines can help the body fight cancer. Mutations in the tumor genome often lead to protein changes that are typical of cancer. A vaccine can alert the patients' immune system to these mutated proteins. For the first time, physicians and cancer researchers from Heidelberg and Mannheim have now carried out a clinical trial to test a mutation-specific vaccine against malignant brain tumors. The vaccine proved to be safe and triggered the desired immune response in the tumor tissue. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 24, 2021 Category: Cancer & Oncology Source Type: news

New cancer immunotherapy recruits help from lymphatic vessels
(University of Chicago) Researchers at the Pritzker School of Molecular Engineering at the University of Chicago have developed a new therapeutic vaccine that uses a patient's own tumor cells to train their immune system to find and kill cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 24, 2021 Category: Cancer & Oncology Source Type: news

Why 2020 was the year of marvellous medicine
A vaccine that could treat multiple types of tumours and stop the cancer from returning has been created in Australia. It could be used against breast, lung, ovarian, kidney and pancreatic cancers. (Source: the Mail online | Health)
Source: the Mail online | Health - March 23, 2021 Category: Consumer Health News Source Type: news

Majority of Cancer Patients with COVID-19 Have similar Immune Response to People Without Cancer
March 22, 2021 (BRONX, NY)— Most people with cancer who are infected by the novel coronavirus produce antibodies at a rate comparable to the rest of the population—but their ability to do so depends on their type of cancer and the treatments they’ve received, according to a new study by researchers atMontefiore Health System andAlbert Einstein College of Medicine. The findings, published online today inNature Cancer, may lead to better care for cancer patients, who face a heightened risk of dying from COVID-19, and suggests that cancer patients should respond well to COVID-19 vaccines. (Source: Einstein News)
Source: Einstein News - March 22, 2021 Category: Universities & Medical Training Source Type: news

Majority of cancer patients with COVID-19 have similar immune response to people without cancer
(Albert Einstein College of Medicine) Most people with cancer who are infected by the novel coronavirus produce antibodies at a rate comparable to the rest of the population - but their ability to do so depends on their type of cancer and the treatments they've received, according to a new study by researchers at Montefiore Health System and Albert Einstein College of Medicine. The findings, published online today in Nature Cancer, may lead to better care for cancer patients, who face a heightened risk of dying from COVID-19, and suggests that cancer patients should respond well to COVID-19 vaccines. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 22, 2021 Category: Cancer & Oncology Source Type: news

A harmless vaccine side effect could mimic cancer in mammograms. Here’s what to know.
Enlarged lymph nodes can be a side effect of vaccination for some people. As harmless as vaccine-swollen nodes are, those in the armpit may appear as alarming white spots in a mammogram. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - March 19, 2021 Category: Consumer Health News Authors: Ben Guarino Source Type: news

Janssen Announces U.S. FDA Approval of PONVORY ™ (ponesimod), an Oral Treatment for Adults with Relapsing Multiple Sclerosis Proven Superior to Aubagio® (teriflunomide) in Reducing Annual Relapses and Brain Lesions
TITUSVILLE, N.J. – (March 19, 2021) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) approved PONVORY™ (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.1,2,3 PONVORY™ offers MS patients superior efficacy in reducing annualized relapse rates compared to an established oral therapy and a proven safety profi...
Source: Johnson and Johnson - March 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Scientist behind coronavirus shot says next target is cancer
The scientist who won the race to deliver the first widely used coronavirus vaccine says people can rest assured the shots are safe (Source: ABC News: Health)
Source: ABC News: Health - March 19, 2021 Category: Consumer Health News Tags: Health Source Type: news

Vaccination by inhalation
(Massachusetts Institute of Technology) MIT researchers have developed a vaccination strategy that can create an army of T cells that can protect mucosal surfaces such as the lungs, offering a quicker response to viral invaders. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 19, 2021 Category: Cancer & Oncology Source Type: news

COVID-19 vaccine: Wondering if I should reschedule my Mammogram?
This article is [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 18, 2021 Category: Databases & Libraries Source Type: news

Mayo Clinic Q & amp;A podcast: Rapid pace of COVID-19 vaccinations
Millions of people in the U.S. are being vaccinated for COVID-19. However, discussion is ongoing as to whether people who are immunocompromised, such as patients undergoing cancer treatment, or people who have autoimmune diseases, should be vaccinated for COVID-19. "Both of those categories (of people) should be vaccinated," says Dr. Gregory Poland, an infectious diseases expert [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 17, 2021 Category: Databases & Libraries Source Type: news

Don't Delay: Patients With Cancer Need Both Doses of COVID Vax Don't Delay: Patients With Cancer Need Both Doses of COVID Vax
For patients with cancer, immune response to the first dose of the Pfizer COVID vaccine is reduced, and there is a need for a booster dose at the recommended 21 days, suggests new UK data.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 16, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Kansas plans to open up vaccinations to about 20% of state's population
Kansas Gov. Laura Kelly announced  the state will combine phases 3 and 4 of its vaccination plan, which now includes people aged 16 through 64 with medical conditions like cancer, diabetes and pregnancy as well as non-health care workers in a number of industries. The governor said Kansans who fall into the new combined phase will be able to get vaccinated starting March 22. The combined phase will cover about 600,000, or about 20%, of the state's 2.9 million residents. Kelly expects Kansas to… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 16, 2021 Category: American Health Authors: FOX4 Kansas City Source Type: news